

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.17682154 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65337610 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.65337610 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31834111 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.31834111 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.91068656 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 6.82290362 |
| 8 | NADH metabolic process (GO:0006734) | 6.57453655 |
| 9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.46309177 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.30442851 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.25745935 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.25745935 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.25745935 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.10997843 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.01022010 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.87697703 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.81995052 |
| 18 | urea cycle (GO:0000050) | 5.81143889 |
| 19 | urea metabolic process (GO:0019627) | 5.81143889 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.72044488 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.61271410 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.52941780 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.51297062 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.48377727 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.47080575 |
| 26 | protein carboxylation (GO:0018214) | 5.47080575 |
| 27 | intestinal absorption (GO:0050892) | 5.46976692 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44125516 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.38539605 |
| 30 | cysteine metabolic process (GO:0006534) | 5.35608937 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.34150431 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.18253503 |
| 33 | regulation of complement activation (GO:0030449) | 5.12691388 |
| 34 | bile acid metabolic process (GO:0008206) | 5.12477316 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 5.01880432 |
| 36 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.94714885 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.89763819 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.87379195 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.86187524 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.84873014 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.83533322 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79724085 |
| 43 | epoxygenase P450 pathway (GO:0019373) | 4.79672648 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.77788766 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.77788766 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.77788766 |
| 47 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.76894347 |
| 48 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.75238099 |
| 49 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.75238099 |
| 50 | endocrine process (GO:0050886) | 4.75238099 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.68651159 |
| 52 | lysine metabolic process (GO:0006553) | 4.61268394 |
| 53 | lysine catabolic process (GO:0006554) | 4.61268394 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.60861903 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.60861903 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.60141482 |
| 57 | antibacterial humoral response (GO:0019731) | 4.56548895 |
| 58 | regulation of cellular extravasation (GO:0002691) | 4.56407060 |
| 59 | phospholipid efflux (GO:0033700) | 4.53667572 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.50171193 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.50171193 |
| 62 | glycine metabolic process (GO:0006544) | 4.46350739 |
| 63 | lipoprotein transport (GO:0042953) | 4.44325798 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.43450872 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.43228944 |
| 66 | antimicrobial humoral response (GO:0019730) | 4.42861634 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.42442596 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.40128049 |
| 69 | adhesion of symbiont to host cell (GO:0044650) | 4.38650573 |
| 70 | virion attachment to host cell (GO:0019062) | 4.38650573 |
| 71 | regulation of systemic arterial blood pressure (GO:0003073) | 4.37972956 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.36792639 |
| 73 | fructose metabolic process (GO:0006000) | 4.36786718 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.35978858 |
| 75 | amine catabolic process (GO:0009310) | 4.33356984 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.33356984 |
| 77 | positive regulation of respiratory burst (GO:0060267) | 4.31144715 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 4.30665102 |
| 79 | cellular glucuronidation (GO:0052695) | 4.30472023 |
| 80 | quinone biosynthetic process (GO:1901663) | 4.29035039 |
| 81 | positive regulation of pseudopodium assembly (GO:0031274) | 4.27228575 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 4.26668152 |
| 83 | glutamate metabolic process (GO:0006536) | 4.24737486 |
| 84 | hormone catabolic process (GO:0042447) | 4.23792197 |
| 85 | regulation of cGMP biosynthetic process (GO:0030826) | 4.21012417 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 4.20325966 |
| 87 | cholesterol efflux (GO:0033344) | 4.19377850 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 4.15918769 |
| 89 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.14210081 |
| 90 | arginine metabolic process (GO:0006525) | 4.12487353 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 4.08925944 |
| 92 | fibrinolysis (GO:0042730) | 4.07798315 |
| 93 | ethanol oxidation (GO:0006069) | 4.06351235 |
| 94 | glycerol metabolic process (GO:0006071) | 4.06266969 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03827999 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 4.03141774 |
| 97 | aldehyde catabolic process (GO:0046185) | 4.01670441 |
| 98 | drug catabolic process (GO:0042737) | 3.99091213 |
| 99 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.98732081 |
| 100 | renal system process involved in regulation of blood volume (GO:0001977) | 3.98472285 |
| 101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96833548 |
| 102 | plasma lipoprotein particle assembly (GO:0034377) | 3.96336205 |
| 103 | peptide catabolic process (GO:0043171) | 3.94867955 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94117016 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.87797610 |
| 106 | positive regulation of protein homodimerization activity (GO:0090073) | 3.85120586 |
| 107 | drug metabolic process (GO:0017144) | 3.84650323 |
| 108 | complement activation (GO:0006956) | 3.84205770 |
| 109 | cofactor catabolic process (GO:0051187) | 3.84107733 |
| 110 | ketone body metabolic process (GO:1902224) | 3.83618121 |
| 111 | protein activation cascade (GO:0072376) | 3.82103743 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.81943436 |
| 113 | uronic acid metabolic process (GO:0006063) | 3.81943436 |
| 114 | regulation of pseudopodium assembly (GO:0031272) | 3.81833222 |
| 115 | cytolysis (GO:0019835) | 3.78264106 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78231157 |
| 117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78231157 |
| 118 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77867180 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76510992 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.74602927 |
| 121 | carboxylic acid catabolic process (GO:0046395) | 3.74278395 |
| 122 | organic acid catabolic process (GO:0016054) | 3.74278395 |
| 123 | adhesion of symbiont to host (GO:0044406) | 3.74174967 |
| 124 | cholesterol homeostasis (GO:0042632) | 3.73619385 |
| 125 | phospholipid homeostasis (GO:0055091) | 3.72836985 |
| 126 | positive regulation of lipid catabolic process (GO:0050996) | 3.70171981 |
| 127 | sterol homeostasis (GO:0055092) | 3.67340480 |
| 128 | acetyl-CoA metabolic process (GO:0006084) | 3.66952409 |
| 129 | cellular response to arsenic-containing substance (GO:0071243) | 3.66805126 |
| 130 | alditol metabolic process (GO:0019400) | 3.66369835 |
| 131 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64143465 |
| 132 | short-chain fatty acid metabolic process (GO:0046459) | 3.61873764 |
| 133 | plasma lipoprotein particle organization (GO:0071827) | 3.61500591 |
| 134 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60474645 |
| 135 | acute-phase response (GO:0006953) | 3.59410388 |
| 136 | NAD biosynthetic process (GO:0009435) | 3.58096037 |
| 137 | regulation of cholesterol homeostasis (GO:2000188) | 3.58037945 |
| 138 | exogenous drug catabolic process (GO:0042738) | 3.57922201 |
| 139 | glomerular filtration (GO:0003094) | 3.56376216 |
| 140 | oligosaccharide biosynthetic process (GO:0009312) | 3.55957930 |
| 141 | regulation of respiratory burst (GO:0060263) | 3.53387968 |
| 142 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.47211876 |
| 143 | germinal center formation (GO:0002467) | 3.46366617 |
| 144 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45672545 |
| 145 | regulation of vitamin metabolic process (GO:0030656) | 3.44629261 |
| 146 | regulation of cGMP metabolic process (GO:0030823) | 3.42093998 |
| 147 | segment specification (GO:0007379) | 3.40545659 |
| 148 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.25046456 |
| 149 | cellular response to nitric oxide (GO:0071732) | 3.22431546 |
| 150 | cGMP-mediated signaling (GO:0019934) | 3.20907883 |
| 151 | renal filtration (GO:0097205) | 3.18335330 |
| 152 | transcytosis (GO:0045056) | 3.17827116 |
| 153 | peptide hormone processing (GO:0016486) | 3.17588144 |
| 154 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.16484180 |
| 155 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.15174154 |
| 156 | sexual reproduction (GO:0019953) | 3.15161382 |
| 157 | digestion (GO:0007586) | 3.15005913 |
| 158 | thyroid gland development (GO:0030878) | 3.05943225 |
| 159 | leukotriene metabolic process (GO:0006691) | 3.02893231 |
| 160 | response to nitric oxide (GO:0071731) | 3.02154037 |
| 161 | glycine transport (GO:0015816) | 3.00907351 |
| 162 | triglyceride biosynthetic process (GO:0019432) | 2.97497994 |
| 163 | carnitine shuttle (GO:0006853) | 2.95235565 |
| 164 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.91867518 |
| 165 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.90477024 |
| 166 | alkaloid metabolic process (GO:0009820) | 2.89677712 |
| 167 | neutral lipid biosynthetic process (GO:0046460) | 2.87736947 |
| 168 | acylglycerol biosynthetic process (GO:0046463) | 2.87736947 |
| 169 | eosinophil chemotaxis (GO:0048245) | 2.87324353 |
| 170 | vitamin transmembrane transport (GO:0035461) | 2.86741706 |
| 171 | ncRNA catabolic process (GO:0034661) | 2.86377301 |
| 172 | flavonoid metabolic process (GO:0009812) | 2.85043716 |
| 173 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.84917867 |
| 174 | hexose catabolic process (GO:0019320) | 2.83854159 |
| 175 | cranial nerve morphogenesis (GO:0021602) | 2.83077448 |
| 176 | cellular response to fluid shear stress (GO:0071498) | 2.81298674 |
| 177 | stress granule assembly (GO:0034063) | 2.76470540 |
| 178 | receptor recycling (GO:0001881) | 2.76404866 |
| 179 | oxaloacetate metabolic process (GO:0006107) | 2.75459343 |
| 180 | sulfate transmembrane transport (GO:1902358) | 2.74767549 |
| 181 | ketone biosynthetic process (GO:0042181) | 2.74293411 |
| 182 | digestive system process (GO:0022600) | 2.73891710 |
| 183 | quinone metabolic process (GO:1901661) | 2.73420235 |
| 184 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73044262 |
| 185 | glucocorticoid biosynthetic process (GO:0006704) | 2.72857610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39815674 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18502587 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.11610459 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48852510 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30938069 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18372523 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81448528 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05718247 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05476215 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.42954381 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23023581 |
| 12 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.21554689 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13946340 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06659969 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0637073 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97796912 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92134960 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87659833 |
| 19 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.86250790 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64414195 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64063778 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59682325 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58025394 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51008712 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.47183293 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45636642 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44717117 |
| 28 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.43904861 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42815536 |
| 30 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.41005858 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40859095 |
| 32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39807153 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38713165 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36650247 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35823500 |
| 36 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30347102 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29816152 |
| 38 | SA1_27219007_Chip-Seq_Bcells_Human | 1.29174232 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29173743 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28764080 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28418837 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26126805 |
| 43 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24961785 |
| 44 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.24268013 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23504812 |
| 46 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22226692 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22014721 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21812099 |
| 49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21785059 |
| 50 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21253915 |
| 51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20682454 |
| 52 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19224582 |
| 53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18255427 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16881674 |
| 55 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13533858 |
| 56 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10928928 |
| 57 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09787724 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09402355 |
| 59 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.08880035 |
| 60 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.08601353 |
| 61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08571751 |
| 62 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08547413 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08501539 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06865876 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05450654 |
| 66 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03572086 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03391873 |
| 68 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02283172 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01435810 |
| 70 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01414713 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00998943 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00813352 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00767935 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99539376 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95598631 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93704644 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93313862 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93042146 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92755709 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92448593 |
| 81 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92205266 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91382155 |
| 83 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91141528 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89536083 |
| 85 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89274866 |
| 86 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89161867 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88763486 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84550308 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83991832 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81430938 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80754910 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80283286 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79148260 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78625467 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78575284 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76794814 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75342694 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74908687 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74420578 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73510211 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69909748 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69437351 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65831981 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65598642 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65092243 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64458060 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63680241 |
| 108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.63277768 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62910742 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62910742 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61795735 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60546693 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60312443 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59707307 |
| 115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56915550 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54511146 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54459451 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52741510 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52405829 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52097359 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51917379 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51784071 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50750780 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50438182 |
| 125 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49116137 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48492915 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47325388 |
| 128 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46779094 |
| 129 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46595871 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44493859 |
| 131 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44187752 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43947996 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42856371 |
| 134 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42591875 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41859578 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.41788028 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40644547 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40452057 |
| 139 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.40132746 |
| 140 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39707813 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39657740 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39496148 |
| 143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39458656 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39328256 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38340938 |
| 146 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37964202 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.37806827 |
| 148 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37706004 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37485537 |
| 150 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37290742 |
| 151 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36150878 |
| 152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36043836 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36036692 |
| 154 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35866188 |
| 155 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34861915 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34221767 |
| 157 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34035137 |
| 158 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33684215 |
| 159 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33504657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.23890323 |
| 2 | MP0005360_urolithiasis | 7.64302834 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44565689 |
| 4 | MP0005365_abnormal_bile_salt | 6.14189843 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19740441 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.28147529 |
| 7 | MP0003252_abnormal_bile_duct | 3.85132900 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.82507033 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.58799653 |
| 10 | MP0009840_abnormal_foam_cell | 3.33111197 |
| 11 | MP0003183_abnormal_peptide_metabolism | 3.19993384 |
| 12 | MP0005083_abnormal_biliary_tract | 3.08203084 |
| 13 | MP0000490_abnormal_crypts_of | 3.04647501 |
| 14 | MP0010155_abnormal_intestine_physiology | 3.00476416 |
| 15 | MP0003195_calcinosis | 2.84465858 |
| 16 | MP0005332_abnormal_amino_acid | 2.78323632 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.66108770 |
| 18 | MP0002009_preneoplasia | 2.63757883 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.57683030 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.40393006 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 2.37686540 |
| 22 | MP0005409_darkened_coat_color | 2.29991136 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.16167788 |
| 24 | MP0000609_abnormal_liver_physiology | 2.15821986 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.12345264 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 2.08648779 |
| 27 | MP0003866_abnormal_defecation | 1.96020559 |
| 28 | MP0001664_abnormal_digestion | 1.94746182 |
| 29 | MP0003868_abnormal_feces_composition | 1.94485181 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.94321424 |
| 31 | MP0001873_stomach_inflammation | 1.93759779 |
| 32 | MP0004147_increased_porphyrin_level | 1.89998077 |
| 33 | MP0000477_abnormal_intestine_morphology | 1.86383295 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.85893182 |
| 35 | MP0000681_abnormal_thyroid_gland | 1.84564763 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.84272326 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.83609206 |
| 38 | MP0001764_abnormal_homeostasis | 1.70333415 |
| 39 | MP0009697_abnormal_copulation | 1.62054141 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.61653551 |
| 41 | MP0002249_abnormal_larynx_morphology | 1.60150362 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56849481 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.56452335 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.52158336 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.44740418 |
| 46 | MP0001663_abnormal_digestive_system | 1.44163002 |
| 47 | MP0005451_abnormal_body_composition | 1.42269844 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.40328212 |
| 49 | MP0003011_delayed_dark_adaptation | 1.38650074 |
| 50 | MP0002006_tumorigenesis | 1.33294272 |
| 51 | MP0003186_abnormal_redox_activity | 1.26963488 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.26715223 |
| 53 | MP0005381_digestive/alimentary_phenotyp | 1.24751304 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.22367509 |
| 55 | MP0000462_abnormal_digestive_system | 1.21382766 |
| 56 | MP0000598_abnormal_liver_morphology | 1.18428886 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.18114804 |
| 58 | MP0005647_abnormal_sex_gland | 1.15331116 |
| 59 | MP0009785_altered_susceptibility_to | 1.12829875 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.10682301 |
| 61 | MP0000604_amyloidosis | 1.10470239 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.08112315 |
| 63 | MP0001849_ear_inflammation | 1.07979964 |
| 64 | MP0009764_decreased_sensitivity_to | 1.06833204 |
| 65 | MP0000566_synostosis | 1.05557753 |
| 66 | MP0004043_abnormal_pH_regulation | 1.03645306 |
| 67 | MP0009763_increased_sensitivity_to | 1.03316212 |
| 68 | MP0004858_abnormal_nervous_system | 1.01955342 |
| 69 | MP0010368_abnormal_lymphatic_system | 1.00796897 |
| 70 | MP0002254_reproductive_system_inflammat | 1.00084405 |
| 71 | MP0005375_adipose_tissue_phenotype | 0.98366892 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.95308165 |
| 73 | MP0001188_hyperpigmentation | 0.92753745 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.91853812 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 0.91245404 |
| 76 | MP0003879_abnormal_hair_cell | 0.91060188 |
| 77 | MP0001790_abnormal_immune_system | 0.91054342 |
| 78 | MP0005387_immune_system_phenotype | 0.91054342 |
| 79 | MP0008469_abnormal_protein_level | 0.90119637 |
| 80 | MP0005025_abnormal_response_to | 0.88503760 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.87094379 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.86655235 |
| 83 | MP0005408_hypopigmentation | 0.86592287 |
| 84 | MP0000538_abnormal_urinary_bladder | 0.86385405 |
| 85 | MP0001800_abnormal_humoral_immune | 0.84126151 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.83651426 |
| 87 | MP0008007_abnormal_cellular_replicative | 0.83405141 |
| 88 | MP0005670_abnormal_white_adipose | 0.81904539 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.81074817 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.80572160 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.79128510 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 0.78195370 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.76037951 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.75834280 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.75765685 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.75261218 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.73216705 |
| 98 | MP0002971_abnormal_brown_adipose | 0.70386637 |
| 99 | MP0006138_congestive_heart_failure | 0.70340709 |
| 100 | MP0009053_abnormal_anal_canal | 0.68211808 |
| 101 | MP0003690_abnormal_glial_cell | 0.67605649 |
| 102 | MP0008004_abnormal_stomach_pH | 0.67422391 |
| 103 | MP0005535_abnormal_body_temperature | 0.67168161 |
| 104 | MP0004130_abnormal_muscle_cell | 0.66854612 |
| 105 | MP0003303_peritoneal_inflammation | 0.66715485 |
| 106 | MP0005334_abnormal_fat_pad | 0.66590370 |
| 107 | MP0001661_extended_life_span | 0.66109788 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.66046054 |
| 109 | MP0005266_abnormal_metabolism | 0.64463529 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.64428044 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.63754185 |
| 112 | MP0003329_amyloid_beta_deposits | 0.63535548 |
| 113 | MP0000639_abnormal_adrenal_gland | 0.62365053 |
| 114 | MP0001756_abnormal_urination | 0.57042292 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.54421856 |
| 116 | MP0005448_abnormal_energy_balance | 0.54070324 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.53933456 |
| 118 | MP0005395_other_phenotype | 0.50222413 |
| 119 | MP0002822_catalepsy | 0.50164185 |
| 120 | MP0003718_maternal_effect | 0.49373953 |
| 121 | MP0008874_decreased_physiological_sensi | 0.46886365 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.46109337 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.46051552 |
| 124 | MP0008873_increased_physiological_sensi | 0.45629861 |
| 125 | MP0003436_decreased_susceptibility_to | 0.44050599 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.43246196 |
| 127 | MP0002928_abnormal_bile_duct | 0.42555947 |
| 128 | MP0003724_increased_susceptibility_to | 0.42439638 |
| 129 | MP0003075_altered_response_to | 0.42041350 |
| 130 | MP0008872_abnormal_physiological_respon | 0.40918833 |
| 131 | MP0005166_decreased_susceptibility_to | 0.40168156 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.40076473 |
| 133 | MP0002837_dystrophic_cardiac_calcinosis | 0.40045180 |
| 134 | MP0004381_abnormal_hair_follicle | 0.39116834 |
| 135 | MP0003953_abnormal_hormone_level | 0.39091949 |
| 136 | MP0000579_abnormal_nail_morphology | 0.38607315 |
| 137 | MP0009672_abnormal_birth_weight | 0.37764276 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.35716681 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.34952006 |
| 140 | MP0000249_abnormal_blood_vessel | 0.32749310 |
| 141 | MP0004883_abnormal_blood_vessel | 0.32500130 |
| 142 | MP0002796_impaired_skin_barrier | 0.32280026 |
| 143 | MP0001243_abnormal_dermal_layer | 0.31786580 |
| 144 | MP0009115_abnormal_fat_cell | 0.31557833 |
| 145 | MP0006082_CNS_inflammation | 0.30140235 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.29881737 |
| 147 | MP0002168_other_aberrant_phenotype | 0.29672145 |
| 148 | MP0002970_abnormal_white_adipose | 0.29641019 |
| 149 | MP0001881_abnormal_mammary_gland | 0.28879913 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.27921458 |
| 151 | MP0002132_abnormal_respiratory_system | 0.27511821 |
| 152 | MP0001853_heart_inflammation | 0.27394086 |
| 153 | MP0005164_abnormal_response_to | 0.25409178 |
| 154 | MP0002060_abnormal_skin_morphology | 0.24144638 |
| 155 | MP0002090_abnormal_vision | 0.23513268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.53860397 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.47678995 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.36256094 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75605969 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.71458499 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.37448998 |
| 7 | Xanthomatosis (HP:0000991) | 6.23559804 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.62056007 |
| 9 | Complement deficiency (HP:0004431) | 5.60036682 |
| 10 | Joint hemorrhage (HP:0005261) | 4.90628481 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.81463239 |
| 12 | Hyperammonemia (HP:0001987) | 4.64597474 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55822038 |
| 14 | Epidermoid cyst (HP:0200040) | 4.45793901 |
| 15 | Hyperglycinemia (HP:0002154) | 4.44820264 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40221029 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.37613776 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31739245 |
| 19 | Widely patent fontanelles and sutures (HP:0004492) | 4.25245092 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.24751248 |
| 21 | Ketosis (HP:0001946) | 4.24175556 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19273860 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18977764 |
| 24 | Fat malabsorption (HP:0002630) | 4.12804461 |
| 25 | Abnormality of complement system (HP:0005339) | 4.09386395 |
| 26 | Decreased circulating renin level (HP:0003351) | 4.06264153 |
| 27 | Metabolic alkalosis (HP:0200114) | 4.05149286 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.94116958 |
| 29 | Hyperglycinuria (HP:0003108) | 3.90408125 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90011311 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.90011311 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86699068 |
| 33 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.79581680 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.78379110 |
| 35 | Chronic diarrhea (HP:0002028) | 3.76259127 |
| 36 | Hyperactive renin-angiotensin system (HP:0000841) | 3.73309938 |
| 37 | Ileus (HP:0002595) | 3.71642727 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65311460 |
| 39 | Pustule (HP:0200039) | 3.64148411 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.56247257 |
| 41 | Abnormality of vitamin B metabolism (HP:0004340) | 3.52874891 |
| 42 | Cerebral palsy (HP:0100021) | 3.40618384 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32803528 |
| 44 | Hyperbilirubinemia (HP:0002904) | 3.32113677 |
| 45 | Reduced antithrombin III activity (HP:0001976) | 3.29119135 |
| 46 | Abnormality of renin-angiotensin system (HP:0000847) | 3.29078341 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28661784 |
| 48 | Wide cranial sutures (HP:0010537) | 3.18679228 |
| 49 | Steatorrhea (HP:0002570) | 3.15229800 |
| 50 | Spontaneous abortion (HP:0005268) | 3.15160813 |
| 51 | Rhabdomyolysis (HP:0003201) | 3.13324227 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 3.11942236 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.08845195 |
| 54 | Confusion (HP:0001289) | 3.08502563 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07761434 |
| 56 | Glycosuria (HP:0003076) | 3.03090045 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 3.03090045 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.97295949 |
| 59 | Ketoacidosis (HP:0001993) | 2.95987008 |
| 60 | Myocardial infarction (HP:0001658) | 2.95792388 |
| 61 | Congenital sensorineural hearing impairment (HP:0008527) | 2.94069328 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.93844109 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.82575720 |
| 64 | Nausea (HP:0002018) | 2.81886404 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.81234282 |
| 66 | Skin nodule (HP:0200036) | 2.76270095 |
| 67 | Metabolic acidosis (HP:0001942) | 2.74605893 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.73894853 |
| 69 | Nephrolithiasis (HP:0000787) | 2.67175053 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.64583673 |
| 71 | Lethargy (HP:0001254) | 2.62695747 |
| 72 | Cheilitis (HP:0100825) | 2.57196130 |
| 73 | Vascular calcification (HP:0004934) | 2.55504388 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55105422 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.55105422 |
| 76 | Glomerulonephritis (HP:0000099) | 2.52998899 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50701702 |
| 78 | Hyperparathyroidism (HP:0000843) | 2.48212100 |
| 79 | Spastic diplegia (HP:0001264) | 2.48125877 |
| 80 | Acanthocytosis (HP:0001927) | 2.47798328 |
| 81 | Cerebral edema (HP:0002181) | 2.46785003 |
| 82 | Posterior subcapsular cataract (HP:0007787) | 2.45556208 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.43124631 |
| 84 | Type I transferrin isoform profile (HP:0003642) | 2.43012985 |
| 85 | Neonatal onset (HP:0003623) | 2.42072022 |
| 86 | Growth hormone excess (HP:0000845) | 2.41966513 |
| 87 | Gout (HP:0001997) | 2.41819852 |
| 88 | Premature loss of primary teeth (HP:0006323) | 2.41651546 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.41500571 |
| 90 | Pigmentary retinal degeneration (HP:0001146) | 2.40892481 |
| 91 | Mitral stenosis (HP:0001718) | 2.40627545 |
| 92 | Abdominal distention (HP:0003270) | 2.40260784 |
| 93 | Hypoglycemic seizures (HP:0002173) | 2.40044144 |
| 94 | Irritability (HP:0000737) | 2.37122989 |
| 95 | J-shaped sella turcica (HP:0002680) | 2.36829545 |
| 96 | Cholelithiasis (HP:0001081) | 2.36782399 |
| 97 | Amyloidosis (HP:0011034) | 2.36098925 |
| 98 | Cervical subluxation (HP:0003308) | 2.34441694 |
| 99 | Gingivitis (HP:0000230) | 2.31767099 |
| 100 | Abnormal biliary tract morphology (HP:0012440) | 2.30496479 |
| 101 | Thin bony cortex (HP:0002753) | 2.29774586 |
| 102 | Gingival bleeding (HP:0000225) | 2.27727742 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.27430228 |
| 104 | Cholecystitis (HP:0001082) | 2.27430228 |
| 105 | Hypotension (HP:0002615) | 2.27265968 |
| 106 | Abnormal urine phosphate concentration (HP:0012599) | 2.27241340 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.26396611 |
| 108 | Amniotic constriction ring (HP:0009775) | 2.21936906 |
| 109 | Abnormality of placental membranes (HP:0011409) | 2.21936906 |
| 110 | Osteomalacia (HP:0002749) | 2.21271531 |
| 111 | Malnutrition (HP:0004395) | 2.20777985 |
| 112 | Esophageal varix (HP:0002040) | 2.19434942 |
| 113 | Menorrhagia (HP:0000132) | 2.19022663 |
| 114 | Myoglobinuria (HP:0002913) | 2.18789555 |
| 115 | Facial shape deformation (HP:0011334) | 2.14447389 |
| 116 | Potter facies (HP:0002009) | 2.14447389 |
| 117 | Hypokalemia (HP:0002900) | 2.13679995 |
| 118 | Thrombophlebitis (HP:0004418) | 2.13219013 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.13123188 |
| 120 | Pancreatitis (HP:0001733) | 2.13087942 |
| 121 | Flat acetabular roof (HP:0003180) | 2.11727076 |
| 122 | Chronic sinusitis (HP:0011109) | 2.10967179 |
| 123 | Agammaglobulinemia (HP:0004432) | 2.10519263 |
| 124 | Proximal tubulopathy (HP:0000114) | 2.10159893 |
| 125 | Enlarged kidneys (HP:0000105) | 2.09717613 |
| 126 | Brushfield spots (HP:0001088) | 2.09394717 |
| 127 | Late onset (HP:0003584) | 2.07701881 |
| 128 | Vomiting (HP:0002013) | 2.06939631 |
| 129 | Eczematoid dermatitis (HP:0000976) | 2.06822047 |
| 130 | Abnormality of the costochondral junction (HP:0000919) | 2.05939972 |
| 131 | Increased purine levels (HP:0004368) | 2.03810072 |
| 132 | Hyperuricemia (HP:0002149) | 2.03810072 |
| 133 | Abnormal tarsal ossification (HP:0008369) | 2.02540199 |
| 134 | Opisthotonus (HP:0002179) | 2.02492699 |
| 135 | Villous atrophy (HP:0011473) | 2.01827681 |
| 136 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.01827681 |
| 137 | Periodontitis (HP:0000704) | 2.01317089 |
| 138 | Hypophosphatemia (HP:0002148) | 2.01093023 |
| 139 | Xerostomia (HP:0000217) | 2.00618506 |
| 140 | Petechiae (HP:0000967) | 1.98872879 |
| 141 | Abnormality of the gallbladder (HP:0005264) | 1.98477080 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.98374800 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.98302325 |
| 144 | Abnormality of potassium homeostasis (HP:0011042) | 1.96239194 |
| 145 | Poikilocytosis (HP:0004447) | 1.96131325 |
| 146 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93825974 |
| 147 | Pili torti (HP:0003777) | 1.92256252 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.88953774 |
| 149 | Rickets (HP:0002748) | 1.87578264 |
| 150 | Hyperaldosteronism (HP:0000859) | 1.86859827 |
| 151 | Increased muscle lipid content (HP:0009058) | 1.86198624 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85770396 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.85408113 |
| 154 | Ankyloglossia (HP:0010296) | 1.84884196 |
| 155 | Alkalosis (HP:0001948) | 1.83716242 |
| 156 | Hypophosphatemic rickets (HP:0004912) | 1.82052096 |
| 157 | Hydroxyprolinuria (HP:0003080) | 1.81968044 |
| 158 | Abnormality of proline metabolism (HP:0010907) | 1.81968044 |
| 159 | Status epilepticus (HP:0002133) | 1.81314345 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80578445 |
| 161 | Renal cortical cysts (HP:0000803) | 1.80401303 |
| 162 | Elevated hepatic transaminases (HP:0002910) | 1.80358496 |
| 163 | Abnormal hair laboratory examination (HP:0003328) | 1.79034997 |
| 164 | Nephritis (HP:0000123) | 1.78573417 |
| 165 | Flared iliac wings (HP:0002869) | 1.77650495 |
| 166 | Megaloblastic anemia (HP:0001889) | 1.77635033 |
| 167 | Right ventricular cardiomyopathy (HP:0011663) | 1.77627283 |
| 168 | Syncope (HP:0001279) | 1.77369550 |
| 169 | Abnormality of vitamin metabolism (HP:0100508) | 1.73347384 |
| 170 | Hyperglycemia (HP:0003074) | 1.72593435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.27985152 |
| 2 | ACVR1B | 6.86516482 |
| 3 | FGFR4 | 4.68874243 |
| 4 | ERN1 | 4.54389843 |
| 5 | SIK1 | 4.45392194 |
| 6 | EPHA2 | 3.64323341 |
| 7 | ERBB4 | 3.14817439 |
| 8 | TAOK3 | 3.11621864 |
| 9 | INSRR | 2.82743412 |
| 10 | PRKG2 | 2.44267334 |
| 11 | MAP2K4 | 2.38138055 |
| 12 | EPHB2 | 2.20233729 |
| 13 | PKN2 | 2.18353520 |
| 14 | MST1R | 2.10556881 |
| 15 | SYK | 1.98597365 |
| 16 | MAPK11 | 1.95973571 |
| 17 | CDK3 | 1.91630552 |
| 18 | FLT3 | 1.85342371 |
| 19 | TRIB3 | 1.82206183 |
| 20 | RIPK4 | 1.77916881 |
| 21 | TYK2 | 1.71817455 |
| 22 | PIK3CG | 1.71299249 |
| 23 | LATS1 | 1.65541862 |
| 24 | CDK19 | 1.58005827 |
| 25 | ABL2 | 1.52856561 |
| 26 | DAPK2 | 1.52642155 |
| 27 | PTK6 | 1.48158449 |
| 28 | KIT | 1.44360012 |
| 29 | LMTK2 | 1.39394987 |
| 30 | NEK9 | 1.38735939 |
| 31 | CAMKK2 | 1.35589318 |
| 32 | FGFR2 | 1.32721536 |
| 33 | KDR | 1.30930080 |
| 34 | FRK | 1.26399340 |
| 35 | JAK2 | 1.25461450 |
| 36 | DDR2 | 1.20368817 |
| 37 | MAP3K7 | 1.18592357 |
| 38 | MATK | 1.18450714 |
| 39 | STK39 | 1.15913272 |
| 40 | TNK2 | 1.15385531 |
| 41 | TESK2 | 1.14502038 |
| 42 | MAP4K1 | 1.13482650 |
| 43 | PINK1 | 1.13037487 |
| 44 | PDK2 | 1.13033377 |
| 45 | GRK6 | 1.12592277 |
| 46 | PRKAA2 | 1.11070249 |
| 47 | ERBB2 | 1.08543616 |
| 48 | MAP2K3 | 1.06056306 |
| 49 | TBK1 | 1.06036589 |
| 50 | JAK1 | 1.00409269 |
| 51 | MAPK4 | 0.98801154 |
| 52 | CDC42BPA | 0.98093300 |
| 53 | MAP3K10 | 0.98044644 |
| 54 | DMPK | 0.92721125 |
| 55 | MAP3K14 | 0.92014471 |
| 56 | PRKCZ | 0.91831331 |
| 57 | STK38L | 0.90714458 |
| 58 | EPHB1 | 0.90349675 |
| 59 | EPHA3 | 0.87094577 |
| 60 | MYLK | 0.86472416 |
| 61 | MET | 0.85686725 |
| 62 | MAP3K3 | 0.83260452 |
| 63 | MAPK12 | 0.82147936 |
| 64 | MAP3K11 | 0.80681540 |
| 65 | MAP3K12 | 0.80502895 |
| 66 | YES1 | 0.79769029 |
| 67 | CDK6 | 0.79666766 |
| 68 | JAK3 | 0.77409381 |
| 69 | OXSR1 | 0.76681062 |
| 70 | MAPK15 | 0.76607915 |
| 71 | TIE1 | 0.76349602 |
| 72 | PRKACG | 0.76123418 |
| 73 | CAMK2G | 0.75742017 |
| 74 | PRPF4B | 0.71700544 |
| 75 | CAMKK1 | 0.71699903 |
| 76 | VRK1 | 0.70932765 |
| 77 | PIM2 | 0.70192628 |
| 78 | HCK | 0.69385299 |
| 79 | MAP3K2 | 0.68571693 |
| 80 | MAP2K6 | 0.68527022 |
| 81 | DYRK1B | 0.68013956 |
| 82 | SMG1 | 0.67239352 |
| 83 | CSK | 0.66947399 |
| 84 | PRKCD | 0.65871849 |
| 85 | NME2 | 0.65688049 |
| 86 | GSK3A | 0.65686018 |
| 87 | PRKAA1 | 0.64017498 |
| 88 | ITK | 0.61602267 |
| 89 | TAOK1 | 0.60209027 |
| 90 | SGK3 | 0.59653355 |
| 91 | RIPK1 | 0.59138697 |
| 92 | CAMK1D | 0.58844222 |
| 93 | IRAK3 | 0.57342037 |
| 94 | VRK2 | 0.57012831 |
| 95 | MAPK7 | 0.56942445 |
| 96 | IKBKE | 0.56735476 |
| 97 | PIM1 | 0.56649571 |
| 98 | FGFR3 | 0.56476135 |
| 99 | STK24 | 0.56017077 |
| 100 | FER | 0.55554970 |
| 101 | TGFBR2 | 0.55283302 |
| 102 | PTK2 | 0.54434579 |
| 103 | CSF1R | 0.54049858 |
| 104 | TESK1 | 0.52323409 |
| 105 | SRC | 0.51967187 |
| 106 | EPHA4 | 0.50363462 |
| 107 | PDPK1 | 0.50041634 |
| 108 | PRKCQ | 0.49697565 |
| 109 | PKN1 | 0.48093385 |
| 110 | TAOK2 | 0.47973109 |
| 111 | FYN | 0.47130878 |
| 112 | CSNK1G1 | 0.46910622 |
| 113 | PRKCE | 0.46061018 |
| 114 | MAP3K13 | 0.45121243 |
| 115 | IKBKB | 0.44897352 |
| 116 | MAP3K5 | 0.44397063 |
| 117 | IGF1R | 0.42976992 |
| 118 | SGK2 | 0.42688318 |
| 119 | RET | 0.42672030 |
| 120 | MAP2K1 | 0.42461961 |
| 121 | GRK1 | 0.42096644 |
| 122 | CDK4 | 0.41774925 |
| 123 | MAP3K6 | 0.41416253 |
| 124 | PRKCG | 0.41161752 |
| 125 | ICK | 0.37961065 |
| 126 | PBK | 0.35761157 |
| 127 | CAMK2D | 0.35278305 |
| 128 | EGFR | 0.34855687 |
| 129 | LATS2 | 0.33925652 |
| 130 | MTOR | 0.33663686 |
| 131 | TNIK | 0.32425039 |
| 132 | PRKCI | 0.32354018 |
| 133 | CAMK4 | 0.32114017 |
| 134 | NLK | 0.32071539 |
| 135 | LRRK2 | 0.31118408 |
| 136 | BTK | 0.29634467 |
| 137 | LYN | 0.29525957 |
| 138 | PDK1 | 0.29216602 |
| 139 | SGK494 | 0.29145392 |
| 140 | SGK223 | 0.29145392 |
| 141 | GRK5 | 0.28153039 |
| 142 | CSNK1G2 | 0.27889471 |
| 143 | MAP3K1 | 0.26786503 |
| 144 | PRKCA | 0.25998833 |
| 145 | IRAK1 | 0.25968041 |
| 146 | CSNK1G3 | 0.25731741 |
| 147 | IRAK2 | 0.22235161 |
| 148 | ABL1 | 0.21508670 |
| 149 | BMX | 0.20963131 |
| 150 | PIK3CA | 0.20612642 |
| 151 | MAP2K2 | 0.20189696 |
| 152 | PAK3 | 0.19939916 |
| 153 | AKT3 | 0.18470468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.58486566 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59503624 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45871872 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34609100 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13417237 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83810440 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.72910005 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69754878 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63206869 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59985408 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56824667 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.56642594 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42867689 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34753220 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22797585 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15170769 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11282427 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.04948123 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.98618471 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97067806 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94383657 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90036645 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88884245 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88508131 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.87590481 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82754700 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80299428 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78885253 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76766002 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74543161 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.71854373 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70837551 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67588259 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63396314 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58870852 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58733202 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57894128 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53312872 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52307936 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.47728446 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44952362 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41342285 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36046783 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35537995 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.34875559 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33034583 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27385784 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26989585 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25417594 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22633152 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21930131 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20918719 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.15244214 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14032519 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11904158 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11357115 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07593040 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04189818 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00300781 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98761603 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98679770 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97065349 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96177117 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94113460 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92716886 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87050636 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83199812 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82061543 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.78402685 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76897424 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70337662 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68176808 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64308669 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63817603 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58583930 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58566021 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57332287 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.54627261 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53887105 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.50301004 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49666642 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46521066 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45744691 |
| 84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45375926 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42637076 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.41476994 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.40624927 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39045971 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31427136 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30695629 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29857441 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29602189 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.27148484 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24575435 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24117697 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23383769 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23206361 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22804425 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.21753797 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20394520 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19724897 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16947393 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15450876 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15009412 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.14312656 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.12987318 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10514419 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09545418 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09362693 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.08886536 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08647118 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01051767 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | -0.2459035 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2449023 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2433293 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | -0.2292818 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2290625 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1945346 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1893350 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1884306 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | -0.1782904 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1775655 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1675757 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1608017 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1591541 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1357762 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1307415 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1202519 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1121643 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0876955 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0758079 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0550285 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0420477 |

